Breakpoints cover image

#64 – Putting the Fun in Fungi: A Fun-guide to New Antifungals

Breakpoints

00:00

Opelkonazole

Opelkonazole is being developed for aerosolized administration. Direct delivery into the lungs has been talked about a long time in the anti-fungal world. This company has taken it now into clinical trials. And so I believe they are either in phase two or phase three. It has pretty good activity against Canada species, including Candor Aris and Candid or Cruciia.

Play episode from 35:04
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app